FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/10/075309 [Registered on: 15/10/2024] Trial Registered Prospectively
Last Modified On: 15/10/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Unani
Other (Specify) [Dry Cupping (Gliding Cupping)]  
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Effectiveness of Hijama with Roghan e Baboona in the treatmentof low back pain 
Scientific Title of Study   A Randomized Controlled Trial to Assess the Effectiveness of Hijamah bila Shart with Roghan e Baboona in Non specific low back pain and its potential role in improving the Quality of Life in Majeedia Unani Hospital South East Delhi 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Shazia Khan 
Designation  MD Scholar 
Affiliation  Jamia Hamdard  
Address  Department of Tahaffuzi wa Samaji Tib School of Unani Medical Education and Research Jamia Hamdard South DELHI 110062 India
Jamia Hamdard New Delhi
South
DELHI
110062
India 
Phone  8383042803  
Fax    
Email  khanshazia1197@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Mo Usman 
Designation  Assistant Professor 
Affiliation  Jamia Hamdard New Delhi 
Address  Department of Tahaffuzi wa Samaji Tib School of Unani Medical Education and Research Jamia Hamdard South DELHI 110062 India
Jamia Hamdard New Delhi
South
DELHI
110062
India 
Phone  8979968072  
Fax    
Email  mousman2010@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Farkhunda Jabin 
Designation  Assistant Professor 
Affiliation  Jamia Hamdard New Delhi 
Address  Department of Ilaj Bil Tadbeer School of Unani Medical Education and Research Jamia Hamdard South Delhi 110062 India
Jamia Hamdard New Delhi
South
DELHI
110062
India 
Phone  7895924502  
Fax    
Email  drfarkhundajabin@jamiahamdard.ac.in  
 
Source of Monetary or Material Support  
Jamia Hamdard New Delhi, India 110062 
 
Primary Sponsor  
Name  Jamia Hamdard 
Address  Department of Tahaffuzi wa Samaji Tib, School of Unani Medical Education and Research, Jamia Hamdard Universiry, Hamdard Nagar New Delhi- 110062 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shazia Khan  Majeedia Unani Hospital  Room NO- 10, OPD Tahaffuzi wa Samaji Tib, Jamia Hamdard University, Hamdard Nagar New Delhi DELHI
South
DELHI 
8383042803

khanshazia1197@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Jamia Hamdard Institutional ethics Committee (JHIEC)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M629||Disorder of muscle, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Habbe Suranjan  Patients will recieve Habbe Suranjan 2 tablets twice a day orally for 2 weeks and after 2 weeks evaluation for efficacy will be recorded 
Intervention  Hijamah-Bila-Shart therapy with Roghan-e-Baboona  Duration of Therapy-15 minutes Total Sittings-7 Patients will receive hijama therapy on alternate days for two weeks and will be evaluated at baseline, at Day 14 (after completion of therapy) and at Day 21 (After one week of treatment free period)  
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Patients of low back pain
2.Oswestry low back pain score up to 24 (mild to moderate disability)
3.willing to take Hijama therapy with Roghan-e-Baboona in experimental group
4. Willing to give written informed consent 
 
ExclusionCriteria 
Details  1. Any previous spine surgery
2. Acute injury of Lumbosacral region
3. Patients with any specific causes of low back pain e.g., Vertebral fracture, herniated disc in the lumbar region, Spinal infections and spinal tumor
4. Major medical illness under treatment
5. Radiological investigation suggestive of any lower back pathology
6.Pregnant women
7. Patients with known skin disorders
8. Patients not in a condition to give valid consent
9. Not willing to participate in the study

 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Visual Analogue Scale
Oswestry Low back Disability Questionnaire 
At baseline at 14 Day (After completion of therapy) and at 21 Day (After one week of treatment free period) 
 
Secondary Outcome  
Outcome  TimePoints 
SF12V2 Quality of Life Questionnaire  At baseline, after completion of therapy at 14 Day and after one week of treatment free period at day 21  
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   28/10/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is Hospital based, Randomized Controlled Trial and conducted on Patients of Non-specific low back pain from OPDs of Majeedia Unani Hospital. The patients are randomly allocated to Experimental and Control group by using alternate method. Group A (Experimental group) will receive Hijama-bila-Shart (Muzliqa/ Gliding Cupping) therapy with Roghan-e-Baboona  for 15 minutes on alternate days for two weeks and Group B (Control group) will receive Standard treatment for low back pain from Ilaj-bil-Tadbeer OPD of Majeedia Unani Hospital and Patients are assessed at baseline, at Day 14 (After the completion of Therapy) and at Day 21 (After one week of treatment free period. The findings will be recorded in Case Report form designed for the study 
Close